May 25, 2017
Tissue-independent cancer drug gets fast-track approval from US regulator
news@nature.com - Fetched: May 25th, 2017, 1:00pm UTC
Treatment will be given on the basis of a tumour’s molecular markers, rather than its location in the body.
Nature News doi: 10.1038/nature.2017.22054